In May 2024, the professional team from VCRO assisted the client in submitting the clinical trial application of their small molecule pharmaceuticals for the treatment of solid tumor. The team successfully obtained TFDA approval to proceed with Phase I clinical trials. We successfully supported our clients in smoothly advancing to the Phase I clinical trial stage. VCRO is here to accompany you through every stage of the clinical trial process.
